Connect your AI

LBRX LBRX Change in Other Assets

Change in Other Assets at other companies

MapLight Therapeutics, Inc. MPLT

-$2.48M-1,382%

Alto NeuroscienceANRO

$4.13M+144%

Zevra Therapeutics, Inc.ZVRA

-$2.05M-618%

Opko HealthOPK

-$6.97M-155%

Acadia PharmaceuticalsACAD

$32K-94.5%

Septerna, Inc.SEPN

$294K-39.8%

Other financials

Income statement

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

Market cap$888.98M+163%

Enterprise value$571.77M—

Returns & leverage

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LBRX's change in other assets?: LBRX (LBRX) reported change in other assets of $10.22M in Q1 2026.
How has LBRX's change in other assets changed year-over-year?: LBRX's change in other assets increased by 12412.0% year-over-year, from -$83K to $10.22M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.